Short Interest in Biomerica, Inc. (NASDAQ:BMRA) Grows By 284.7%

Biomerica, Inc. (NASDAQ:BMRA) was the target of a large growth in short interest in November. As of November 30th, there was short interest totalling 1,430,000 shares, a growth of 284.7% from the November 15th total of 371,700 shares. Based on an average daily trading volume, of 844,900 shares, the days-to-cover ratio is presently 1.7 days.

Biomerica Trading Down 3.4 %

Shares of NASDAQ BMRA traded down $0.01 during midday trading on Wednesday, hitting $0.29. 144,084 shares of the company’s stock were exchanged, compared to its average volume of 408,170. Biomerica has a 12-month low of $0.24 and a 12-month high of $2.13. The company has a market cap of $4.88 million, a price-to-earnings ratio of -0.81 and a beta of -1.10. The business’s fifty day moving average price is $0.34 and its two-hundred day moving average price is $0.38.

Biomerica (NASDAQ:BMRA) last issued its quarterly earnings data on Tuesday, October 15th. The company reported ($0.08) EPS for the quarter. Biomerica had a negative return on equity of 84.62% and a negative net margin of 111.89%. The business had revenue of $1.81 million for the quarter.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Biomerica stock. Perritt Capital Management Inc acquired a new position in shares of Biomerica, Inc. (NASDAQ:BMRA) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 70,000 shares of the company’s stock, valued at approximately $31,000. Perritt Capital Management Inc owned approximately 0.42% of Biomerica at the end of the most recent quarter. Institutional investors and hedge funds own 22.28% of the company’s stock.

Biomerica Company Profile

Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.